ZNF865 Gene Shows Promise in Slowing Spinal Disc Degeneration in Lab Studies

Lab research indicates ZNF865 gene activity may reverse spinal disc deterioration markers in human and rat cells, though human treatments remain distant.

Human disc cells from back pain and trauma patients show significantly lower ZNF865 expression in degenerative states compared to healthy cells. Silencing this gene in degenerative disc cells increased senescence markers fivefold, while upregulating it reduced senescence markers to near-healthy levels and boosted collagen production. In rats, CRISPR-based ZNF865 depletion triggered disc disease symptoms within two months. The study confirms ZNF865 links to DNA repair and cellular replication pathways but notes no existing therapies target this gene. Current results are limited to lab cells from small human cohorts and rat models—no human trials have been conducted. While this pathway could eventually address back pain costs, it remains experimental with unknown mechanisms in living humans. The research advances potential future pathways for mobility and care needs but does not yet deliver affordable solutions.

Source: Lifespan.io